Dana-Farber Cancer Institute will pay $15m to resolve allegations that it violated the False Claims Act by making false statements related to National Institutes of Health (NIH) research grants.
The Boston-based cancer treatment and research center “caused the submission of false claims to NIH by falsely certifying compliance with grant

